Clinical Trial Update: The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety and potential efficacy of umbilical cord blood mononuclear cells in patients with secondary poor graft fu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poor Graft Function After Hematopoietic Stem Cell Transplantation

Drugs mentioned

• Umbilical Cord Blood Mononuclear Cells

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Poor Graft Function | Phase 1 | Status: RECRUITING